257 related articles for article (PubMed ID: 31136210)
1. Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments.
Suarez-Kelly LP; Baldi GG; Gronchi A
Expert Opin Pharmacother; 2019 Aug; 20(12):1503-1515. PubMed ID: 31136210
[No Abstract] [Full Text] [Related]
2. Established and Experimental Systemic Treatment Options for Advanced Liposarcoma.
Schöffski P
Oncol Res Treat; 2022; 45(9):525-543. PubMed ID: 35609512
[TBL] [Abstract][Full Text] [Related]
3. Managing Liposarcomas: Cutting Through the Fat.
Manji GA; Schwartz GK
J Oncol Pract; 2016 Mar; 12(3):221-7. PubMed ID: 26962163
[TBL] [Abstract][Full Text] [Related]
4. Current management options for liposarcoma and challenges for the future.
Kollár A; Benson C
Expert Rev Anticancer Ther; 2014 Mar; 14(3):297-306. PubMed ID: 24397249
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines].
Italiano A; Toulmonde M; Bui-Nguyen B
Bull Cancer; 2010 Jun; 97(6):679-86. PubMed ID: 20483708
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for liposarcoma: current and emerging synthetic treatments.
Chamberlain F; Benson C; Thway K; Huang P; Jones RL; Gennatas S
Future Oncol; 2021 Jul; 17(20):2659-2670. PubMed ID: 33880964
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological therapies for Liposarcoma.
Saponara M; Stacchiotti S; Gronchi A
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):361-377. PubMed ID: 28135854
[TBL] [Abstract][Full Text] [Related]
8. Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?
Ratan R; Patel SR
Curr Treat Options Oncol; 2017 Jun; 18(6):34. PubMed ID: 28534249
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of trabectedin for the treatment of liposarcoma.
Zijoo R; von Mehren M
Expert Opin Pharmacother; 2016 Oct; 17(14):1953-62. PubMed ID: 27615729
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Treatment of Myxoid Liposarcomas: Histology Matters.
Abaricia S; Hirbe AC
Curr Treat Options Oncol; 2018 Oct; 19(12):64. PubMed ID: 30362022
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
Keung EZ; Lazar AJ; Torres KE; Wang WL; Cormier JN; Ashleigh Guadagnolo B; Bishop AJ; Lin H; Hunt KK; Bird J; Lewis VO; Patel SR; Wargo JA; Somaiah N; Roland CL
BMC Cancer; 2018 Sep; 18(1):913. PubMed ID: 30249211
[TBL] [Abstract][Full Text] [Related]
12. Eribulin in soft-tissue sarcoma.
Young RJ; Woll PJ
Lancet; 2016 Apr; 387(10028):1594-6. PubMed ID: 26874886
[No Abstract] [Full Text] [Related]
13. Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan.
Nakamura T; Asanuma K; Hagi T; Sudo A
Drug Des Devel Ther; 2020; 14():4215-4220. PubMed ID: 33116409
[TBL] [Abstract][Full Text] [Related]
14. Application of molecular biology to individualize therapy for patients with liposarcoma.
Abbas Manji G; Singer S; Koff A; Schwartz GK
Am Soc Clin Oncol Educ Book; 2015; ():213-8. PubMed ID: 25993159
[TBL] [Abstract][Full Text] [Related]
15. Sarcoma: Eribulin--a welcomed advance.
Romero D
Nat Rev Clin Oncol; 2016 Apr; 13(4):204. PubMed ID: 26925959
[No Abstract] [Full Text] [Related]
16. Therapeutic Targets for Bone and Soft-Tissue Sarcomas.
Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Tsuchiya H
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621224
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.
De Sanctis R; Marrari A; Marchetti S; Mussi C; Balzarini L; Lutman FR; Daolio P; Bastoni S; Bertuzzi AF; Quagliuolo V; Santoro A
Drug Des Devel Ther; 2015; 9():5785-91. PubMed ID: 26604682
[TBL] [Abstract][Full Text] [Related]
18. Long-term eribulin treatment in patients with a single kidney and retroperitoneal liposarcoma.
Tober N; Gentile M; Iodice G
Future Oncol; 2020 Jan; 16(1s):5-8. PubMed ID: 31872769
[TBL] [Abstract][Full Text] [Related]
19. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
Ryan CW; Desai J
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
[TBL] [Abstract][Full Text] [Related]
20. Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review.
Assi T; Ngo C; Faron M; Verret B; Lévy A; Honoré C; Hénon C; Le Péchoux C; Bahleda R; Le Cesne A
Curr Treat Options Oncol; 2023 Nov; 24(11):1598-1613. PubMed ID: 37843627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
